Moisi Marc, Cruz Aurora S, Benkers Tara, Rostad Steven, Broyles Frances Broyles, Yuen Kevin, Mayberg Marc
Seattle Science Foundation ; Neurological Surgery, Wayne State University.
Neurological Surgery, University of Louisville ; Neurological Surgery, University of California, Irvine ; Neurological Surgery, Swedish Neuroscience Institute.
Cureus. 2016 Jun 27;8(6):e658. doi: 10.7759/cureus.658.
Most prolactin-secreting pituitary adenomas demonstrate slow growth and are effectively managed with medical/surgical therapy. Rarely, these tumors can behave aggressively with rapid growth and invasion of local tissues, and are refractory to medical, surgical, or radio-surgical therapies. We report a case of a prolactin-secreting adenoma in a young woman, which became progressively aggressive and refractory to usual treatment modalities, but responded to treatment with the chemotherapeutic agent temozolomide. In addition, we review the literature for treatment of refractory adenomas with temozolomide. The clinical and pathologic characteristics of aggressive prolactin-secreting adenomas are reviewed, as well as their response to dopamine agonists, surgery, radiotherapy, and chemotherapy.
大多数分泌催乳素的垂体腺瘤生长缓慢,通过药物/手术治疗可得到有效控制。这些肿瘤极少会表现出侵袭性,生长迅速并侵犯局部组织,且对药物、手术或放射外科治疗均无效。我们报告了一例年轻女性分泌催乳素的腺瘤病例,该肿瘤逐渐变得具有侵袭性,对常规治疗方式无效,但对化疗药物替莫唑胺治疗有反应。此外,我们查阅了用替莫唑胺治疗难治性腺瘤的文献。本文回顾了侵袭性分泌催乳素腺瘤的临床和病理特征,以及它们对多巴胺激动剂、手术、放疗和化疗的反应。